Bullement A, Edmondson-Jones M, Latimer N. Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach. BMC Cancer 2024;24:879.
PMID: 39039442